Search

everythinglearnresearchcommunity

for

Search:↓

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Improving medical training is key to eradicating frambusia by 2030.

Chitosan-encapsulated Cordyceps militaris reduces lung cell damage from pollution.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Tofacitinib is effective and safe for treating alopecia areata.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

The nanogel with Ciclopirox Olamine is a promising treatment for skin yeast infections.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Minoxidil may protect the brain from damage by preventing cell death and energy loss.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Bicalutamide may help treat female pattern hair loss.

Baricitinib successfully treated severe hair loss.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.